ACS Webinar - Mini-Chemical MBA: Equity Financing, SAFEs, and Convertible Notes
Raising capital is more than closing a round, it’s negotiating your company’s future.
Join Samuel Beavers and Joseph Flynn of Goodwin Procter LLP as they deliver a practical, market-driven roadmap to funding early-stage companies in today’s evolving venture landscape. They will break down the stages of capital raising and compare convertible notes with SAFEs as well as unpack the key economic and control terms in venture deals while offering timely insight into VC, healthtech, and life sciences market trends. Register now to develop a clear, strategic approach to structuring financings, managing investor dynamics, and positioning your company for long-term success in a competitive fundraising market.
This ACS Webinar is moderated by Olivia Uitto of Goodwin Procter LLP and co-produced with the ACS Division of Small Chemical Businesses. As part of ACS's ongoing celebration of our 150th anniversary, this month we highlight interdisciplinary collaboration. As the central science, chemistry connects disciplines and enables breakthroughs in sustainability, health, technology, and beyond. Celebrate with us at www.acs.org/150.
What You Will Learn
- How early-stage financings are structured, from SAFEs and convertible notes to preferred equity, and when to use each
- The key economic and control terms investors negotiate, and how they affect founders and future rounds
- Current venture capital trends across tech, healthtech, and life sciences